Usgena
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Usgena, covering 2025-11-21 to 2026-08-11. Get the full timeline:
Most recent: EMA Authorised: Usgena (ustekinumab) — Stada Arzneimittel AG
2 regulatory and trial events tracked for Usgena, covering 2025-11-21 to 2026-08-11. Get the full timeline:
Most recent: EMA Authorised: Usgena (ustekinumab) — Stada Arzneimittel AG